Ligand Pharmaceuticals
LGND
LGND
329 hedge funds and large institutions have $3.26B invested in Ligand Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 118 increasing their positions, 125 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
39% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 71
49% less call options, than puts
Call options by funds: $61.7M | Put options by funds: $122M
Holders
329
Holding in Top 10
4
Calls
$61.7M
Puts
$122M
Top Buyers
| 1 | +$49.8M | |
| 2 | +$47.3M | |
| 3 | +$35.9M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$23.4M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$21.6M |
Top Sellers
| 1 | -$67.8M | |
| 2 | -$44.7M | |
| 3 | -$43.5M | |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$29.8M |
| 5 |
D.E. Shaw & Co
New York
|
-$19.2M |